News

Low flu jab uptake for at-risk groups

02-Feb-07

Flu vaccination
Patients with respiratory disease such as COPD are not coming forward for flu jabs this winter, according to DoH figures, which also revealed low uptake in patients with chronic liver and renal disease.

The figures for the provisional national flu vaccination uptake to the end of December 2006 in England show that large numbers of patients within medical risk groups have not been vaccinated. But 72 per cent of patients aged 65 and over received the vaccination, passing the national target of 70 per cent set by the Joint Committee on Vaccination and Immunisation.

Experts said that there were a number of factors that could be affecting the uptake figures despite GP efforts.

Chairman of the General Practice Airways Group (GPIAG) and Somerset GP Dr Steve Holmes said that he encouraged immunisation for those with chronic respiratory disease. He thought the low figure for this group may be due to how the figures were compiled.

'The uptake number may be low in the chronic respiratory group depending on how they counted the patients,' he said.

sanjay.tanday@haymarket.com  

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Registrar

Golden rules for registrars

Medico-legal adviser Dr Jim Rodger offers some expert advice on how to excel as a GP registrar. Read more

Career paths - Working abroad in a rural practice

Dr Kingsley Poole describes the differences he experienced working at a remote practice in New Zeala... Read more

Professional development - Honing your presentation skills

Most people feel nervous facing an audience, but practice will make it easier, says Dr Kevin Brown. Read more

Show all articles

 

Latest Clinical Articles

Clinical Review - Malaria

Contributed by Dr Charlie Easmon specialist adviser in travel medicine and medical director at The N... Read more

Clinical Review - Renal colic

Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more

Clinical Review - Stroke

By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more

Show all clinical articles

MIMS Product News

New drug - Xamiol

Leo Pharma has launched Xamiol gel, a combination of calcipotriol + betamethasone, for the treatment... Read more

New drug - Xarelto

Bayer HealthCare has launched Xarelto (rivaroxaban) for the prevention of venous thromboembolism in ... Read more

New drug - Torisel

Wyeth has launched Torisel (temsirolimus), a first-line treatment for advanced renal cell carcinoma ... Read more

Jobs

 

Job of the Week